Premier Biomedical, Inc. (OTCMKTS:BIEI) Stock Short Interest Report for October

Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report) saw a large growth in short interest in October. As of October 30th, there was short interest totaling 39,000 shares. Based on an average daily volume of 16,150,651 shares, the days-to-cover ratio is presently 0.0 days.

Premier Biomedical Price Performance

BIEI opened at $0.00 on Tuesday. Premier Biomedical has a 1 year low of $0.00 and a 1 year high of $0.00.

About Premier Biomedical

(Get Free Report)

Premier Biomedical, Inc. is a development-stage biotechnology company focused on researching and developing therapies for serious medical conditions. Its work has included potential treatments for cancer, chronic pain, depression, post-traumatic stress disorder and other diseases. The company has described proprietary approaches involving the selective removal or modification of substances in the blood, as well as drug-delivery technologies intended to improve the administration of therapeutic compounds.

Further Reading

Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.